
Dr. Jeffery Wilkins and the research staff are conducting a double-blinded, randomized, placebo-controlled research study of the Prometa Treatment Protocol for the treatment of alcohol dependence. The study is conducted through the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center. Qualified participants may receive up to $470 for participation in the 16-week study.
The purpose of the study is to determine the effectiveness and safety of select medications used in a new treatment regimen. Cedars-Sinai hopes these findings will lead to better treatments for alcohol dependency and abuse.
Participation is open to anyone who is:
Alcoholism and alcohol abuse do not discriminate by gender, race or nationality. In the United States, approximately one in every 12 adults (more than 17 million people) abuse alcohol.
Alcoholism is a chronic disease where there is a continued use of alcohol despite negative social and health consequences. Alcoholics risk employment and relationships to satisfy this need.
Symptoms of alcoholism, include:
To find out more about the clinical trials on alcoholism or to enroll, please contact us at:
| Psychiatry Research at the Thalians Mental Health Center |
| Cedars-Sinai Medical Center |
| 8730 Alden Dr., Room E-123 |
| Los Angeles, CA 90048 |
| Phone: 310-423-4551 or 310-423-4320 |
| Send Us a Message |
© Copyright 2000-2009 Cedars-Sinai Health System.
All
rights reserved.
Privacy Policy
Terms and Conditions
